mail
versión imprimible
 
 

iPSC-Derived Cell Therapies Summit

Evvnt Promotion / evvnt
-
07.12.2021 - 09.12.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temas de la conferencia
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/853667-3?pid=4832

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
 

Información e inscripción:

https://go.evvnt.com/853667-1?pid=4832
Mr. Customer Services
 
Categorías
Investigación clínica, Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1899.00 - USD 3597.00
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellenceSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Gesellschaft für Public Health